Clidinium bromide

An anticholinergic drug used to treat peptic ulcers and other gastrointestinal disorders

Clidinium bromide
INN
Drug class
Routes of administration
Pregnancy category
Bioavailability
Metabolism
Elimination half-life
Excretion
Legal status
CAS Number
PubChem
DrugBank
ChemSpider
KEGG

Clidinium bromide is an anticholinergic drug that is used in combination with other medications to treat peptic ulcers and other gastrointestinal disorders. It is often combined with chlordiazepoxide in a formulation known as Librax.

Pharmacology

Clidinium bromide works by reducing the secretions of certain organs in the body. It is an anticholinergic agent, which means it blocks the action of the neurotransmitter acetylcholine in the central nervous system and peripheral nervous system. This action helps to decrease the muscle spasms in the gastrointestinal tract and reduce the production of stomach acid.

Medical uses

Clidinium bromide is primarily used to treat:

• Peptic ulcers
• Irritable bowel syndrome (IBS)
• Gastroesophageal reflux disease (GERD)
• Spastic colon

Side effects

Common side effects of clidinium bromide include:

• Dry mouth
• Blurred vision
• Constipation
• Drowsiness

Less common side effects may include:

• Urinary retention
• Tachycardia
• Confusion

Contraindications

Clidinium bromide should not be used in individuals with:

• Glaucoma
• Myasthenia gravis
• Prostatic hypertrophy

Mechanism of action

Clidinium bromide exerts its effects by blocking the muscarinic acetylcholine receptors in the smooth muscle of the gastrointestinal tract. This leads to a reduction in muscle spasms and a decrease in the secretion of stomach acids.

History

Clidinium bromide was first introduced in the 1960s and has been used in combination with other medications to treat various gastrointestinal disorders. Its combination with chlordiazepoxide, a benzodiazepine, is particularly popular for its dual action of reducing anxiety and gastrointestinal symptoms.

Related pages

• Anticholinergic
• Peptic ulcer disease
• Irritable bowel syndrome
• Gastroesophageal reflux disease